Página principal > Resultados de la búsqueda: Mollà, Meritxell
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 5 registros encontrados en 0.02 segundos.
Artículos, Encontrados 5 registros
Artículos Encontrados 5 registros  
1.
6 p, 636.0 KB Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain / Borras, Josep M. (Institut d'Investigació Biomèdica de Bellvitge) ; Font, R. (Catalunya. Generalitat) ; Solà, J. (Catalunya. Generalitat) ; Macia, M. (Institut Català d'Oncologia) ; Tuset, V. (Institut Català d'Oncologia) ; Arenas, M. (Universitat Rovira i Virgili) ; Eraso, Arantxa (Institut Català d'Oncologia) ; Verges, R. (Hospital Universitari Vall d'Hebron) ; Farré, Núria (Institut d'Investigació Biomèdica Sant Pau) ; Pedro, Agustí (Institut d'Investigació Biomèdica Sant Pau) ; Mollà, Meritxell (Hospital Clínic i Provincial de Barcelona) ; Algara, Manuel (Hospital del Mar (Barcelona, Catalunya)) ; Solé, J.M. (Consorci Sanitari de Terrassa) ; Mira, M. (Hospital Universitari Arnau de Vilanova) ; Espinàs, J.A. (Catalunya. Generalitat) ; Universitat Autònoma de Barcelona
This study aims to assess the effects of non-adherence to external beam radiation therapy in cancer patients receiving treatment with a curative. This retrospective cohort study collected health records data for all cancer patients treated with external beam radiotherapy with curative intent in 2016 in Catalonia, Spain. [...]
2020 - 10.1016/j.radonc.2020.08.002
Radiotherapy and Oncology, Vol. 151 (october 2020) , p. 200-205  
Registro completo - Creative Commons
2.
8 p, 998.3 KB Evidence-based guidelines for hypofractionated radiation in breast cancer : conclusions of the Catalan expert working group / Eraso, Arantxa (Institut Català d'Oncologia (Girona, Catalunya). Radiation Oncology Department) ; Sanz, Javier (Hospital del Mar (Barcelona, Catalunya)) ; Mollà, Meritxell (Hospital Clínic i Provincial de Barcelona) ; Reyes López, Victoria (Hospital Universitari Vall d'Hebron) ; Pedro, Agustí (Institut d'Investigació Biomèdica Sant Pau) ; Arenas, Meritxell (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Martinez, Evelyn (Institut Català d'Oncologia. Hospital Duran i Reynals. Servei d'Oncologia Radioteràpica) ; Ballester Alabau, Rosa (Institut Català d'Oncologia Badalona. Servei d'Oncologia Radioteràpica) ; Cambra, Maria José (Hospital General de Catalunya. Servei d'Oncologia Radioteràpica) ; García, Virginia (Hospital Universitari Arnau de Vilanova) ; Prades, Joan Lluis (Pla Director d'Oncologia de Catalunya. Institut Català d'Oncologia. Hospital Duran i Reynals) ; Borras, Josep M. (Pla Director d'Oncologia de Catalunya. Institut Català d'Oncologia. Hospital Duran i Reynals) ; Algara, Manuel (Institut Hospital del Mar d'Investigacions Mèdiques)
Introduction: Daily, moderate hypofractionation has become standard treatment for breast cancer following breast-conserving surgery, although substantial variation exists in its use. This paper describes the generation of consensus-based recommendations for the utilisation of this therapy at the healthcare system level and compares these to American Society for Radiation Oncology (ASTRO) guidelines. [...]
2022 - 10.1007/s12094-022-02798-8
Clinical & Translational Oncology, Vol. 24 Núm. 8 (august 2022) , p. 1580-1587  
Registro completo - Creative Commons
3.
16 p, 3.2 MB Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT / Molla, Meritxell (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernandez-Plana, Julen (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ; Albiol, Santiago (Hospital Clínic i Provincial de Barcelona) ; Fondevila, Constantino (Hospital Clínic i Provincial de Barcelona) ; Vollmer, Ivan (Hospital Clínic i Provincial de Barcelona) ; Cases, Carla (Hospital Clínic i Provincial de Barcelona) ; García-Criado, A. (Hospital Clínic i Provincial de Barcelona) ; Capdevila Castillón, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Conill, Carles (Hospital Clínic i Provincial de Barcelona) ; Fundora, Yliam (Hospital Clínic i Provincial de Barcelona) ; Fernández-Martos, Carlos (Instituto Valenciano Oncologia) ; Pineda, Estela (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
The prognosis for oligometastatic colorectal cancer has improved in recent years, mostly because of recent advances in new techniques and approaches to the treatment of oligometastases, including new surgical procedures, better systemic treatments, percutaneous ablation, and stereotactic body radiation therapy (SBRT). [...]
2021 - 10.3390/jcm10102131
Journal of clinical medicine, Vol. 10 (may 2021)  
Registro completo - Creative Commons
4.
15 p, 2.1 MB Tetraploidy-associated genetic heterogeneity confers chemo-radiotherapy resistance to colorectal cancer cells / Galofré, Claudia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Gönül Geyik, Öykü (Dokuz Eylul University. Department of Medical Biology) ; Asensio, Elena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Wangsa, Darawalee (National Institute of Health (Bethesda, EUA)) ; Hirsch, Daniela (National Institute of Health (Bethesda, EUA)) ; Parra, Carolina (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Saez, Jordi (Hospital Clínic i Provincial de Barcelona) ; Mollà, Meritxell (Hospital Clínic i Provincial de Barcelona) ; Yüce, Zeynep (Dokuz Eylul University. Department of Medical Biology) ; Castells, Antoni (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ried, Thomas (National Institute of Health (Bethesda, EUA)) ; Camps, Jordi (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia)
Tetraploidy, or whole-genome duplication, is a common phenomenon in cancer and preludes chromosome instability, which strongly correlates with disease progression, metastasis, and treatment failure. Therefore, it is reasonable to hypothesize that tetraploidization confers multidrug resistance. [...]
2020 - 10.3390/cancers12051118
Cancers, Vol. 12, issue 5 (May 2020) , art. 1118  
Registro completo - Creative Commons
5.
14 p, 502.9 KB Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe / Pinato, David J. (Imperial College London. Department of Surgery & Cancer) ; Lee, Alvin J. X. (University College London Hospitals) ; Biello, Federica (University of Piemonte Orientale) ; Seguí, Elia (Hospital Clínic i Provincial de Barcelona) ; Aguilar-Company, Juan (Hospital Universitari Vall d'Hebron) ; Carbó, Anna (Hospital Universitari de Girona Doctor Josep Trueta) ; Bruna, Riccardo (University of Piemonte Orientale) ; Bower, Mark (Chelsea & Westminster Hospital) ; Rizzo, Gianpiero (Fondazione IRCCS Policlinico San Matteo) ; Benafif, Sarah (University College London Hospitals) ; Carmona, Carme (Hospital Universitari de Girona Doctor Josep Trueta) ; Chopra, Neha (University College London Hospitals) ; Cruz, Claudia Andrea (Hospital Clínic i Provincial de Barcelona) ; D'avanzo, Francesca (University of Piemonte Orientale) ; Evans, Joanne S. (Imperial College London) ; Galazi, Myria (University College London Hospitals) ; Garcia-Fructuoso, Isabel (Hospital Universitari de Girona Doctor Josep Trueta) ; Pria, Alessia D. (Chelsea & Westminster Hospital) ; Newsom-Davis, Thomas (Chelsea & Westminster Hospital) ; Ottaviani, Diego (University College London Hospitals) ; Patriarca, Andrea (University of Piemonte Orientale) ; Reyes, Roxana (Hospital Clínic i Provincial de Barcelona) ; Sharkey, Rachel (University of Piemonte Orientale) ; Sng, Christopher C. T. (University College London Hospitals) ; Wong, Yien Ning Sophia (University College London Hospitals) ; Ferrante, Daniela (University of Piemonte Orientale) ; Scotti, Lorenza (University of Piemonte Orientale) ; Avanzi, Gian Carlo (University of Piemonte Orientale) ; Bellan, Mattia (University of Piemonte Orientale) ; Castello, Luigi Mario (University of Piemonte Orientale) ; Marco-Hernández, Javier (Hospital Clínic i Provincial de Barcelona) ; Mollà, Meritxell (Hospital Clínic i Provincial de Barcelona) ; Pirisi, Mario (University of Piemonte Orientale) ; Ruiz-Camps, Isabel (Hospital Universitari Vall d'Hebron) ; Sainaghi, Pier Paolo (University of Piemonte Orientale) ; Gaidano, Gianluca (University of Piemonte Orientale) ; Brunet, Joan (Hospital Universitari de Girona Doctor Josep Trueta) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Prat, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Gennari, Alessandra (University of Piemonte Orientale) ; Universitat Autònoma de Barcelona
We describe the outcomes in cancer patients during the initial outbreak of the COVID-19 in Europe from the retrospective, multi-center observational OnCovid study. We identified 204 cancer patients from eight centers in the United Kingdom, Italy, and Spain aged > 18 (mean = 69) and diagnosed with COVID-19 between February 26th and April 1st, 2020. [...]
2020 - 10.3390/cancers12071841
Cancers, Vol. 12 Núm. 7 (july 2020) , p. 1-13  
Registro completo - Creative Commons

Vea también: autores con nombres similares
3 Molla, M.
5 Molla, Meritxell
3 Mollà, M.
3 Mollá, M.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos